Emily M Hsieh

Assistant Professor of Clinical Pediatrics

Is this your profile? Click to edit

Publications

Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell FailureTransplant Cell Ther. 2023 09; 29(9):574. e1-574. e10. . View in PubMed
Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults Blood Adv. 2024 Jul 09; 8(13):3544-3548. . View in PubMed
INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities Transplant Cell Ther. 2024 Jan; 30(1):38-55. . View in PubMed
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy Blood Adv. 2022 09 13; 6(17):5222-5226. . View in PubMed
Chimeric antigen receptor T cells for mature B-cell lymphoma and Burkitt lymphoma Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):487-493. . View in PubMed
Replacing CAR-T cell resistance with persistence by changing a single residue J Clin Invest. 2020 06 01; 130(6):2806-2808. . View in PubMed
Gene Therapy: Current Applications and Future Possibilities Adv Pediatr. 2019 08; 66:37-54. . View in PubMed
Medication use in the neonatal intensive care unit Am J Perinatol. 2014 Oct; 31(9):811-21. . View in PubMed
Management of autism in the adult intensive care unit J Intensive Care Med. 2014 Jan-Feb; 29(1):47-52. . View in PubMed